Literature DB >> 31502093

Onychomycosis Associated with Superficial Skin Infection Due to Aspergillus sydowii in an Immunocompromised Patient.

Parismita Borgohain1, Purnima Barua2, Pranjal Jyoti Dutta3, Dipika Shaw4, Shivaprakash M Rudramurthy4.   

Abstract

Opportunistic fungal infections of the skin and nail are frequently encountered in human. Recent years have shown increased incidence of fungal infections especially in immunocompromised patients. Onychomycosis in HIV-infected patients is reported to occur in 15-40%, four times more than in the general population. Here, we report a case of fingernail proximal subungual onychomycosis with associated skin infection caused by an opportunistic mold, Aspergillus sydowii, in a HIV positive individual. Isolation of A. sydowii from nail and skin of an immunocompromised person needs accurate identification for successful treatment.

Entities:  

Keywords:  Aspergillus spp.; Immunocompromised patient; Onychomycosis; Proximal subungual onychomycosis

Mesh:

Year:  2019        PMID: 31502093     DOI: 10.1007/s11046-019-00383-2

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  45 in total

1.  Genetic diversity of Aspergillus species isolated from onychomycosis and Aspergillus hongkongensis sp. nov., with implications to antifungal susceptibility testing.

Authors:  Chi-Ching Tsang; Teresa W S Hui; Kim-Chung Lee; Jonathan H K Chen; Antonio H Y Ngan; Emily W T Tam; Jasper F W Chan; Andrea L Wu; Mei Cheung; Brian P H Tse; Alan K L Wu; Christopher K C Lai; Dominic N C Tsang; Tak-Lun Que; Ching-Wan Lam; Kwok-Yung Yuen; Susanna K P Lau; Patrick C Y Woo
Journal:  Diagn Microbiol Infect Dis       Date:  2015-11-03       Impact factor: 2.803

2.  New drugs for the nail fungus prevalent in elderly.

Authors:  P Phillips
Journal:  JAMA       Date:  1996-07-03       Impact factor: 56.272

Review 3.  Origins of onychomycosis.

Authors:  D J McCarthy
Journal:  Clin Podiatr Med Surg       Date:  1995-04       Impact factor: 1.231

4.  Aspergillus in patient care areas.

Authors:  L G Herman
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

5.  [A case of onychomycosis caused by Aspergillus sydowii].

Authors:  Ayako Yamada; Hiromitsu Noguchi; Hitoko Sakae; Takashi Sugita; Midori Hiruma; Masataro Hiruma
Journal:  Med Mycol J       Date:  2012

6.  Update on the management of onychomycosis: highlights of the Third Annual International Summit on Cutaneous Antifungal Therapy.

Authors:  B E Elewski; R J Hay
Journal:  Clin Infect Dis       Date:  1996-08       Impact factor: 9.079

7.  Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex.

Authors:  D S Goodman; E D Teplitz; A Wishner; R S Klein; P G Burk; E Hershenbaum
Journal:  J Am Acad Dermatol       Date:  1987-08       Impact factor: 11.527

8.  Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS).

Authors:  M H Kaplan; N Sadick; N S McNutt; M Meltzer; M G Sarngadharan; S Pahwa
Journal:  J Am Acad Dermatol       Date:  1987-03       Impact factor: 11.527

9.  The rise and fall of a six-year coral-fungal epizootic.

Authors:  Kiho Kim; C Drew Harvell
Journal:  Am Nat       Date:  2004-11       Impact factor: 3.926

10.  Relationship between Fungal Colonisation of the Respiratory Tract in Lung Transplant Recipients and Fungal Contamination of the Hospital Environment.

Authors:  Christine Bonnal; Christopher Leleu; Olivier Brugière; Christian Chochillon; Raphael Porcher; Pierre-Yves Boelle; Jean Menotti; Sandrine Houze; Jean-Christophe Lucet; Francis Derouin
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

View more
  1 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.